| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | -37.2% |
| Cost of Revenue | $2.6M | -31.0% |
| R&D Expense | $5.2M | +26.8% |
| SG&A Expense | $25.7M | -17.0% |
| Operating Income | -$36.6M | -1.9% |
| Interest Expense | $1.2M | -49.7% |
| Pre-tax Income | $47.8M | +236.1% |
| Income Tax | $13K | +160.0% |
| Net Income | $47.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.3M | +20.6% |
| Short-term Investments | $495K | -98.7% |
| Accounts Receivable | $309K | +93.1% |
| Inventory | $1.2M | +6.0% |
| Current Assets | $24.6M | -55.7% |
| Total Assets | $47.5M | -39.0% |
| Current Liabilities | $13.8M | -25.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.3M | +5.6% |
| Capital Expenditures | $364K | -80.1% |
| Investing Cash Flow | $36.5M | +239.5% |
| Financing Cash Flow | -$507K | -101.2% |
| Free Cash Flow | -$28.7M | +9.8% |
| +236.1% |
| EPS (Basic) | $5.73 | +197.8% |
| EPS (Diluted) | $5.72 | +197.6% |
| Long-term Debt |
| $5.8M |
| -58.2% |
| Total Liabilities | $25.7M | -77.4% |
| Stockholders' Equity | $21.8M | +160.8% |